The Benefit of Adding Fish Oil to the Nutrition of Critically Ill Patients

University Medicine Greifswald

Status and phase: Completed; Phase 4

Conditions: Sepsis Syndrome

Treatments: Drug: Defined percentage of omega-3-fatty acids

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00142220

OMEGAVEN

Details and patient eligibility

About

We study whether an increased proportion of omega-3-fatty acids (contained in fish oil) in the nutrition of critically ill patients reduces systemic inflammation.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• indication for parenteral nutrition

Exclusion criteria

• hypertriglyceridemia
• coagulation disorder
• decompensated liver cirrhosis or acute liver failure

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind